Opportunity AssessmentCase Study
Evaluation of the market potential for an asset being developed for a chronic respiratory indication
The Situation
- Bluestar was engaged by a pharmaceutical company to evaluate the U.S. market opportunity for an early development stage asset being developed for the treatment of a chronic respiratory condition
The Ask
- Client sought an assessment of the patient segmentation, unmet needs, reaction to a target product profile (TPP) and key product attributes, likely adoption of the product, and the evolving competitive landscape
- Client wanted an independent revenue forecast as part of the analysis
The Actions
1
Primary Research
- Conducted in-depth interviews with more than 30 physicians across a variety of specialties involved in the management of the disease, including key opinion leaders and academic and community physicians
- Interviews provided feedback on patient management, unmet needs, future competitors, the TPP, and potential adoption
2
Secondary Research
- Assessed disease overview and epidemiology, diagnosis, patient segmentation, size of the addressable patient population, patient journey, and treatment paradigm
- Provided an overview of the development pipeline
3
Financial Forecasting
- Constructed a revenue forecast with adjustable metrics to understand sensitivities around key variables, including patient segments, market share, price, and treatment response rate
The Impact
Delivered a detailed overview of the disease, patient segmentation, patient flow, competitive landscape, and treatment paradigm
Gained feedback on the TPP across various product attributes and assessed how the product may be adopted across relevant patient segments in the future treatment landscape
Developed a detailed revenue forecast with variable assumption toggles to both evaluate key sensitives and be able to refine the forecast as additional data emerged
Representative Deliverables
Patient Segmentation
Competitive Landscape
Addressable Market
Revenue Forecast
